AugustBioservices
Provides contract development and manufacturing for sterile injectable drugs.
Company facts
- Founded
- 2017
- Employees
- 150
- Headquarters
- United States
- CEO
- Jenn Adams
- Type
- Private
- Funding
- Series B · $65M · 2022
About
August Bioservices is a US-based, quality-driven Contract Development and Manufacturing Organization (CDMO) specializing in sterile injectable solutions. Headquartered in Nashville, Tennessee, August Bioservices offers comprehensive support including end-to-end drug research and development, cGMP laboratory services, and sterile fill/finish manufacturing. Given its focus on aseptic processes and terminally sterilized filling, the company caters to pharmaceutical and biotechnology clients with a commitment to excellence and quality. The organization has also undergone significant expansion to enhance its manufacturing capacity and capabilities, further solidifying its reputation as a reliable partner in the pharmaceutical sector. With a robust leadership team supported by decades of industry experience, August Bioservices is equipped with state-of-the-art technology to meet the rigorous demands of drug development and manufacturing. This positions them uniquely in the market, enabling them to support clients from the initial formulation development stage through to commercial production.